Expanding the Foundation for Personalized Medicine

Personalized medicine aims to individualize care based on a person’s unique genetic, environmental, and clinical profile. Dentists and physicians have long recognized variations between and among patients, and have customized care based on each individual’s health history, environment, and behavior. However, the sequencing of the human genome in 2003 and breakthroughs in regenerative medicine, imaging, and computer science redefined “personalized medicine” as clinical care that takes advantage of new molecular tools to facilitate highly precise health care based on an individual’s unique genomic and molecular characteristics. Major investments in science bring a new urgency toward realizing the promise of personalized medicine; yet, many challenges stand in the way. In this article, we present an overview of the opportunities and challenges that influence the oral health community’s full participation in personalized medicine. We highlight selected research advances that are solidifying the foundation of personalized oral health care, elaborate on their impact on dentistry, and explore obstacles toward their adoption into practice. It is our view that now is the time for oral health professionals, educators, students, researchers, and patients to engage fully in preparations for the arrival of personalized medicine as a means to provide quality, customized, and effective oral health care for all.

[1]  R. Gibbs,et al.  Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1 , 2011, Science.

[2]  Eric Bair,et al.  Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. , 2011, The journal of pain : official journal of the American Pain Society.

[3]  L. Ellisen,et al.  The molecular pathogenesis of head and neck squamous cell carcinoma. , 2012, The Journal of clinical investigation.

[4]  P. Dayer,et al.  Impact of environmental and genetic factors on codeine analgesia , 2004, European Journal of Clinical Pharmacology.

[5]  C. Chung,et al.  Therapeutic targets in head and neck squamous cell carcinoma: identification, evaluation, and clinical translation. , 2012, Oral oncology.

[6]  Jessica L. Mark Welch,et al.  Systems-level analysis of microbial community organization through combinatorial labeling and spectral imaging , 2011, Proceedings of the National Academy of Sciences.

[7]  A. Jemal,et al.  Cancer statistics, 2012 , 2012, CA: a cancer journal for clinicians.

[8]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[9]  John T McDevitt,et al.  Current developments in salivary diagnostics. , 2010, Biomarkers in medicine.

[10]  Joshua P Cohen.  Overcoming regulatory and economic challenges facing pharmacogenomics. , 2012, New biotechnology.

[11]  David Elashoff,et al.  Prevalidation of Salivary Biomarkers for Oral Cancer Detection , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[12]  Eneida A. Mendonça,et al.  Clinical decision support systems: perspectives in dentistry. , 2004, Journal of dental education.

[13]  J. McDevitt,et al.  Nano-Bio-Chip Sensor Platform for Examination of Oral Exfoliative Cytology , 2010, Cancer Prevention Research.

[14]  V. Patel,et al.  Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model , 2009, Cancer Prevention Research.

[15]  Wendy A. Wolf,et al.  The eMERGE Network: A consortium of biorepositories linked to electronic medical records data for conducting genomic studies , 2011, BMC Medical Genomics.

[16]  N. D’Silva,et al.  Biomarkers of Epithelial-Mesenchymal Transition in Squamous Cell Carcinoma , 2013, Journal of dental research.

[17]  D. Weeks,et al.  Heritable patterns of tooth decay in the permanent dentition: principal components and factor analyses , 2012, BMC oral health.

[18]  Shashi Amur,et al.  Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use , 2008, Pharmacotherapy.

[19]  Y. Daali,et al.  Codeine intoxication associated with ultrarapid CYP2D6 metabolism. , 2004, The New England journal of medicine.

[20]  Paul G Shekelle,et al.  Delivery of genomic medicine for common chronic adult diseases: a systematic review. , 2008, JAMA.

[21]  Robert J. Palmer,et al.  Communication among Oral Bacteria , 2002, Microbiology and Molecular Biology Reviews.

[22]  F. Collins,et al.  The path to personalized medicine. , 2010, The New England journal of medicine.

[23]  M. Bissell,et al.  Use of Saliva-Based Nano-Biochip Tests for Acute Myocardial Infarction at the Point of Care: A Feasibility Study , 2011 .

[24]  R. Drmanac.  The advent of personal genome sequencing , 2011, Genetics in Medicine.

[25]  D. Malamud,et al.  Saliva as a diagnostic fluid. , 1992, BMJ.

[26]  C. Melander,et al.  A New Small Molecule Specifically Inhibits the Cariogenic Bacterium Streptococcus mutans in Multispecies Biofilms , 2011, Antimicrobial Agents and Chemotherapy.

[27]  M. Marazita,et al.  Taste Genes Associated with Dental Caries , 2010, Journal of dental research.

[28]  G. Illei,et al.  MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndrome. , 2011, Arthritis and rheumatism.

[29]  C. R. Leemans,et al.  Molecular analysis of surgical margins in head and neck cancer: more than a marginal issue. , 2010, Oral oncology.

[30]  R. Kent,et al.  Microbiota of Severe Early Childhood Caries before and after Therapy , 2011, Journal of dental research.

[31]  D. B. Ferguson,et al.  Potential uses of human salivary protein and peptide analysis in the diagnosis of disease. , 2012, Archives of oral biology.

[32]  G. Ginsburg,et al.  Genome technologies and personalized dental medicine. , 2012, Oral diseases.

[33]  F. Collins.  Reengineering Translational Science: The Time Is Right , 2011, Science Translational Medicine.

[34]  R. Ohrbach,et al.  Summary of findings from the OPPERA baseline case-control study: implications and future directions. , 2011, The journal of pain : official journal of the American Pain Society.

[35]  R. Kent,et al.  Cultivable Anaerobic Microbiota of Severe Early Childhood Caries , 2011, Journal of Clinical Microbiology.

[36]  P. Slootweg,et al.  Treatment failure and margin status in head and neck cancer. A critical view on the potential value of molecular pathology. , 2002, Oral oncology.

[37]  P. Workman,et al.  Discovery of small molecule cancer drugs: Successes, challenges and opportunities , 2012, Molecular oncology.

[38]  Susan Hart-Hester,et al.  Integrating medical and dental records. A new frontier in health information management. , 2010, Journal of AHIMA.

[39]  Amy L McGuire,et al.  Paving the Way to Personalized Genomic Medicine: Steps to Successful Implementation. , 2009, Current pharmacogenomics and personalized medicine.

[40]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[41]  Wen-Han Yu,et al.  The Human Oral Microbiome Database: a web accessible resource for investigating oral microbe taxonomic and genomic information , 2010, Database J. Biol. Databases Curation.

[42]  Heiko Spallek,et al.  From information technology to informatics: the information revolution in dental education. , 2012, Journal of dental education.

[43]  C. Serhan,et al.  Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation , 2012, Front. Immun..

[44]  Titus Schleyer,et al.  Electronic dental record use and clinical information management patterns among practitioner-investigators in The Dental Practice-Based Research Network. , 2013, Journal of the American Dental Association.

[45]  J. Grandis,et al.  Investigational EGFR-targeted therapy in head and neck squamous cell carcinoma , 2010, Expert opinion on investigational drugs.

[46]  Dan M. Roden,et al.  Implementing genomic medicine in the clinic: the future is here , 2013, Genetics in Medicine.

[47]  A. McKenna,et al.  The Mutational Landscape of Head and Neck Squamous Cell Carcinoma , 2011, Science.

[48]  L. Elferink,et al.  Receptor-Tyrosine-Kinase-Targeted Therapies for Head and Neck Cancer , 2011, Journal of signal transduction.

[49]  T. Cabras,et al.  Biotechnological implications of the salivary proteome. , 2011, Trends in biotechnology.

[50]  Martin Renqiang Min,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[51]  F. Collins.  Has the revolution arrived? , 2010, Nature.